Speaker illustration

Doctor Victoria Orshanskaya

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)

Histomolecular fibrotic profile and an extent of the atrial and ventricular electroanatomical substrate in patients with atrial fibrillation and heart failure

Event: ESC Congress 2020

Topic: Heart Failure in Atrial Fibrillation

Session: Atrial Fibrillation ePosters

Thumbnail

Personalized interventional strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session: Rapid Fire 1: atrial fibrillation ablation: alternatives to improve success

Thumbnail

Personalized ablation strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure.

Event: ESC Congress 2018

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation - Ablation

Thumbnail

Association between an extent of electroanatomical substrate, circulating pro-fibrotic biomarkers and myocardial tissue morphology in patients with atrial fibrillation and heart failure.

Event: EHRA 2018

Topic: Heart Failure in Atrial Fibrillation

Session: Atrial fibrillation - Clinical

Thumbnail

Relationship between an extent of electroanatomical substrate, serum pro-fibrotic biomarkers and histopathological data in patients with atrial fibrillation and heart failure.

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention

Thumbnail

Relationship of the extent of left atrial electroanatomical substrate and risk of thromboembolic events in patients with atrial fibrillation.

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Best Posters in risk assessment of thromboembolic events in atrial fibrillation

Thumbnail

ESC 365 is supported by